Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Extension of Givinostat in Polyarticular Juvenile Idiopathic Arthritis
2011-003341-18Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- Sep 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of givinostat in juvenile idiopathic arthritis (JIA), sponsored by Italfarmaco. Primary endpoint: Long-term safety of Givinostat. Started Sep 2011; status: completed.
02
Drugs
givinostat
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2011-003341-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003341-18.